Related Experiment Videos

Promyelocytic leukemia protein (PML) and Daxx participate in a novel nuclear pathway for apoptosis

S Zhong1, P Salomoni, S Ronchetti

  • 1Department of Human Genetics and the Molecular Biology Program, Memorial Sloan-Kettering Cancer Center, Sloan-Kettering Division, Graduate School of Medical Sciences, Cornell University, New York, New York 10021, USA.

Insights

Promyelocytic leukemia protein (PML) and Daxx cooperate in nuclear bodies to promote apoptosis. PML is crucial for Daxx

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • The promyelocytic leukemia protein (PML) gene is a tumor suppressor crucial for apoptosis.
  • Daxx is involved in the Fas proapoptotic pathway.

Purpose of the Study:

  • To investigate the interaction between PML and Daxx in apoptosis.
  • To elucidate the role of PML nuclear bodies (NBs) in Daxx-mediated apoptosis.

Main Methods:

  • Studied mitogenically activated splenic lymphocytes.
  • Analyzed Daxx and PML localization in nuclear bodies.
  • Assessed the impact of PML absence on Daxx function and apoptosis.

Main Results:

  • Daxx accumulates in PML NBs upon lymphocyte activation, where PML and Daxx interact.
  • PML absence causes dispersed nuclear Daxx and impairs activation-induced cell death.
  • PML inactivation abrogates Daxx's proapoptotic function.
  • In acute promyelocytic leukemia (APL) cells, Daxx delocalizes from NBs but relocalizes upon retinoic acid treatment.

Conclusions:

  • PML and Daxx collaborate in a novel NB-dependent apoptotic pathway.
  • PML is essential for Daxx's proapoptotic activity and nuclear localization.
  • This interaction sheds light on PML's tumor suppressor functions and APL pathogenesis.

Related Concept Videos